Physician profile
Robert E Rainer
NPI 1093820151
$266.38
in general payments reported to CMS, 2019-2025
10 companies · $89.66 in 2025
The $89.66 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.34 · 2020: $25.32 · 2021: $53.76 · 2022: $21.67 · 2023: $19.68 · 2024: $40.95 · 2025: $89.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $150.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $64.33 | 2023-2025 | Veozah |
| Evofem Biosciences, INC. | $44.09 | 2022-2024 | |
| Shield Therapeutics INC | $26.48 | 2025 | |
| Abbvie INC. | $25.32 | 2020 | |
| Viiv Healthcare Company | $20.64 | 2025 | Apretude |
| Avion Pharmaceuticals | $18.78 | 2021 | |
| Hologic Sales and Service, LLC | $18.63 | 2021 | |
| Mayne Pharma Commercial LLC | $16.42 | 2025 | |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Therapeuticsmd, INC. | $15.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rainer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.